Atrys Health, S.A. (BME:ATRY)

Spain flag Spain · Delayed Price · Currency is EUR
2.710
+0.010 (0.37%)
At close: Dec 5, 2025
-11.73%
Market Cap 204.86M
Revenue (ttm) 226.24M
Net Income (ttm) -24.59M
Shares Out 75.87M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE 29.80
Dividend n/a
Ex-Dividend Date n/a
Volume 83,786
Average Volume 143,295
Open 2.700
Previous Close 2.700
Day's Range 2.660 - 2.770
52-Week Range 2.480 - 3.670
Beta 0.60
RSI 39.08
Earnings Date Nov 14, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,045
Stock Exchange Madrid Stock Exchange
Ticker Symbol ATRY
Full Company Profile

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.

Financial Statements

News

There is no news available yet.